We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Ordering of Alzheimer Disease Biomarkers—Reply

Clifford R. Jack, MD
Arch Neurol. 2012;69(3):414-415. doi:10.1001/archneurol.2011.2908.
Text Size: A A A
Published online


In reply

We appreciate the opportunity to respond to the critique of our paper “Evidence for ordering of Alzheimer disease biomarkers.”1 In their critique, Glodzik et al stated, “Cross-sectional data presenting percentages of abnormal values across 3 static diagnostic categories cannot be substituted for observing within subject temporal trajectories of changes.” While we explicitly stated that additional longitudinal data are needed, we believe the logic of our approach is sound. If 1 biomarker crosses the threshold from normal to abnormal earlier than another as the disease progresses, it follows that the earlier changing biomarker should be abnormal more often in a sample of subjects that span the cognitive continuum than a biomarker that crosses the normal-to-abnormal threshold later. Furthermore, comparing how often a biomarker is abnormal across multiple subjects is very analogous to the classic approach taken by Braak and Braak.2 Through autopsy studies of individuals spanning all ages, Braak and Braak developed a scheme to stage the topographic spread of Alzheimer disease pathologies. A time element is inherent in their staging. The major difference from our approach is that in the Braak and Braak approach, subjects were arrayed on the x-axis by age; in our approach, subjects were arrayed on the x-axis by disease severity—both age and disease severity increment by time. We find it odd that in the same letter critiquing our cross-sectional approach, Glodzik et al later supported their “tau-comes-first” position with references to Braak autopsy data.2 Autopsies surely represent the ultimate form of cross-sectional data.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





March 1, 2012
Lidia Glodzik, MD, PhD; James Galvin, MD, MPH; Elizabeth Pirraglia, BA, MA; Mony de Leon, EdD
Arch Neurol. 2012;69(3):414-415. doi:10.1001/archneurol.2011.2906.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
Alzheimer Disease: "It's OK, Mama, If You Want to Go, It's OK"

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Supplemental Content